Loading
ReproCELL Incorporated: what insiders have been doing
Every trade that managers of ReproCELL Incorporated disclose to EDINET (Japan FSA) is tracked on this page. Between 18 October 2025 and 18 October 2026, 2 insiders published 9 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Insider buying of ReproCELL Incorporated has been absent for the past year. Filings reach the EDINET (Japan FSA) feed a median of 7 days after the trade. This delay matters because a trade only becomes useful information once it is public.
With 9 filings in twelve months, the company is more active than the median of 3 filings across the 3,419 companies we follow on the same exchange.
These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
Insider Decl.
15
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 20,441 of 24,148 companies
27.1
score / 100
Value23
Quality32
FCF yld-4.0%
Earn yld-4.9%
EV/EBITDA·
ROE-4.9%
Gross mgn45%
Net mgn-26%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
JP¥127
Analyst consensus
Income statement
RevenueJP¥2.2B
Gross profitJP¥1B45% margin
EBITDA-JP¥785.1M-35% margin
Net income-JP¥591.7M-18.9% margin
Valuation
P/Book1.4x
Beta0.54
Balance sheet & cash
Market capJP¥12.4B
Total debtJP¥80M
Free Cash Flow-JP¥481.7M
Profitability & ownership
ROE-4.9%
ROA-5.8%
% insiders6.0%
% institutions6.6%
Last declaration on 25 September 2026
Declarations15 total
ShareXTKSEDINET:S100Z38E
1.0% of flowShareXTKSEDINET:S100Z1VA
37.1% of flowShareXTKSEDINET:S100Z1C1
ShareXTKSEDINET:S100Z0AC
ShareXTKSEDINET:S100YUR7
0.6% of flowShareXTKSEDINET:S100YSKI
28.7% of flowShareXTKSEDINET:S100YS6A
0.3% of flowShareXTKSEDINET:S100YG2C
32.3% of flowShareXTKSEDINET:S100YDCB
ShareXTKSEDINET:S100U2TF
ShareXTKSEDINET:S100TZS8
ShareXTKSEDINET:S100TATT
ShareXTKSEDINET:S100T0CV
46.7% of flowShareXTKSEDINET:S100SPEK
53.3% of flowShareXTKSEDINET:S100SJUO
15 of 15 declarations
About ReproCELL Incorporated
Reprocell Inc. is a Japanese company listed on the XTKS market, specializing in the development of cell reprogramming technologies. It focuses on applications in regenerative medicine and biotechnology.